More science – Bursting with ideas


Idorsia began its operations after the demerger from Actelion on June 15, 2017, with registered shares of Idorsia Ltd being listed on the SIX Swiss Exchange the following day. Today, Idorsia has an experienced team of highly qualified professionals, a full R&D pipeline, state-of-the-art facilities, and a healthy balance sheet – the ideal constellation for bringing successful medicines to the market. 

Idorsia is so much more than a start-up!

Our Strategy

Our Strategy

Find out more about how Idorsia intends to deliver on its ambitious goals.

Idorsia pipeline

Idorsia pipeline

See an overview of Idorsia's clinical development pipeline.

History

History

Learn more about how Idorsia came to life.

"We are all encouraged to talk, share, communicate and participate."

Clinical Research Associate, Global Operations